Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Baker

Showing results (1221-1230 of 3,734) with videos related to

Pageof 374
Sort By:
Microbiome|April 30, 2015
Genomic resolution of linkages in carbon, nitrogen, and sulfur cycling among widespread estuary sediment bacteriaBrett J Baker, Cassandre Sara Lazar, Andreas P Teske, et al.
BMC Bioinformatics|July 6, 2015
PredSTP: a highly accurate SVM based model to predict sequential cystine stabilized peptidesS M Ashiqul Islam, Tanvir Sajed, Christopher Michel Kearney, et al.
Systematic Biology|July 31, 2007
Mitochondrial and nuclear DNA sequences support a Cretaceous origin of Columbiformes and a dispersal-driven radiation in the Paleocene Sergio L Pereira, Kevin P Johnson, Dale H Clayton, et al.
The Journal of Biological Chemistry|June 13, 2006
Heparin modulates the 99-loop of factor IXa: effects on reactivity with isolated Kunitz-type inhibitor domainsPierre F Neuenschwander, Stephen R Williamson, Armen Nalian, et al.
BJS Open|May 20, 2020
Liquid biopsy for cancer diagnosis using vibrational spectroscopy: systematic reviewD J Anderson, R G Anderson, S J Moug, et al.
The Journal of Experimental Medicine|May 1, 1980
The role of specific antibody in alternative complement pathway-mediated opsonophagocytosis of type III, group B StreptococcusM S Edwards, A Nicholson-Weller, C J Baker, et al.
Journal of Periodontal Research|September 1, 1978
The in vitro inhibition of microbial growth and plaque formation by surfactant drugsP J Baker, R A Coburn, R J Genco, et al.
Molecular Genetics and Metabolism Reports|September 1, 2022
Pegvaliase dose escalation to 80 mg daily may lead to efficacy in patients who do not exhibit an optimal response at lower dosesErika R Vucko, Kirsten E Havens, Joshua J Baker, et al.
Infection and Immunity|September 1, 1978
Association of elevated levels of extracellular neuraminidase with clinical isolates of type III group B streptococciT W Milligan, C J Baker, D C Straus, et al.
Journal of Dental Research|June 1, 1977
Comparison of antiplaque agents using an in vitro assay reflecting oral conditionsR T Evans, P J Baker, R A Coburn, et al.
Pageof 374

Showing results (1221-1230 of 3,734) with videos related to

Sort By:
Pageof 374
Microbiome|April 30, 2015
Genomic resolution of linkages in carbon, nitrogen, and sulfur cycling among widespread estuary sediment bacteriaBrett J Baker, Cassandre Sara Lazar, Andreas P Teske, et al.
BMC Bioinformatics|July 6, 2015
PredSTP: a highly accurate SVM based model to predict sequential cystine stabilized peptidesS M Ashiqul Islam, Tanvir Sajed, Christopher Michel Kearney, et al.
Systematic Biology|July 31, 2007
Mitochondrial and nuclear DNA sequences support a Cretaceous origin of Columbiformes and a dispersal-driven radiation in the Paleocene Sergio L Pereira, Kevin P Johnson, Dale H Clayton, et al.
The Journal of Biological Chemistry|June 13, 2006
Heparin modulates the 99-loop of factor IXa: effects on reactivity with isolated Kunitz-type inhibitor domainsPierre F Neuenschwander, Stephen R Williamson, Armen Nalian, et al.
BJS Open|May 20, 2020
Liquid biopsy for cancer diagnosis using vibrational spectroscopy: systematic reviewD J Anderson, R G Anderson, S J Moug, et al.
The Journal of Experimental Medicine|May 1, 1980
The role of specific antibody in alternative complement pathway-mediated opsonophagocytosis of type III, group B StreptococcusM S Edwards, A Nicholson-Weller, C J Baker, et al.
Journal of Periodontal Research|September 1, 1978
The in vitro inhibition of microbial growth and plaque formation by surfactant drugsP J Baker, R A Coburn, R J Genco, et al.
Molecular Genetics and Metabolism Reports|September 1, 2022
Pegvaliase dose escalation to 80 mg daily may lead to efficacy in patients who do not exhibit an optimal response at lower dosesErika R Vucko, Kirsten E Havens, Joshua J Baker, et al.
Infection and Immunity|September 1, 1978
Association of elevated levels of extracellular neuraminidase with clinical isolates of type III group B streptococciT W Milligan, C J Baker, D C Straus, et al.
Journal of Dental Research|June 1, 1977
Comparison of antiplaque agents using an in vitro assay reflecting oral conditionsR T Evans, P J Baker, R A Coburn, et al.
Pageof 374